Translational research funding boost
24 November 2017
A prestigious award from the National Health and Medical Research Council (NHMRC) has been presented to Associate Professor Rachael Morton, an Investigator at Melanoma Institute Australia and Research Theme Leader for Society, Policy and Economics.
The NHMRC Translating Research Into Practice (TRIP) Fellowship aims to support future leaders to undertake projects focused on translating evidence into practice that will have a deep impact on health care.
The funding will help researchers at Melanoma Institute Australia continue their ground-breaking research in melanoma that will change the way melanoma treatment is assessed in the future.
A/Prof Morton will use the funding to incorporate Patient Reported Outcome Measures (PROMs) into clinical quality registries.
“PROMs are an important method to better understand outcomes that matter to patients and include any metric assessing health, illness or health care benefits from the patient’s perspective, such as a questionnaire,” explains A/Prof Morton. “In the clinic, PROMs have the potential to highlight relevant symptoms and changes in symptoms, promote patient engagement in their treatment and improve patient outcomes.”
“Instruments measuring the patient’s perspective have been available for decades; however their incorporation into routine clinical practice has until recently been slow. We hope to facilitate this process.”
The work from this Fellowship will help integrate PROMs into the new Australian Clinical Outcomes Register for Melanoma, also known as the Big Data for Melanoma project, which has been made possible by collective fundraising efforts from the national Melanoma March campaign.
On Friday, a publication that lays out the steps needed to find out if a systematic screening program for melanoma would benefit all Australians was published in the Australia & New Zealand Journal of Public Health.
Melanoma March events have been cancelled. A Virtual March will be held on Sunday 29th March. Read this statement from MIA CEO Matthew Browne.
Thank you to the thousands of Aussies who bought ‘Game On Mole‘ t-shirts, took selfies, shared t-shirt pics on social media and started lifesaving conversations around sun safety and skin health.
Melanoma patients now have greater access to subsidised immunotherapy thanks to additional treatments today being listed on the PBS.
Brisbane couple Leon and Tamra Betts were, like thousands of others around Australia, on the couch watching MAFS when newlywed Natasha ran through her weekly beauty routine. When they heard the 26-year-old mention solarium use, they were shocked, and then saddened, prompting this open letter to all young Australians.
Professor Richard Scolyer, Co-Medical Director of Melanoma Institute Australia, will welcome international attendees this weekend to a sold-out, two-day course on ‘Pigmented Lesions and Other Hot Topics in Dermatopathology’.
It is time for a reality check on solariums.
They have no place in anyone’s beauty routine.
Throughout January our community created, hosted and participated in some amazing events, each of them helping us on our quest to reach zero deaths from melanoma.
Australian television presenter, interior designer and mother Kyly Clarke has been announced as the new Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign Melanoma March.
Melanoma Institute Australia has recently partnered with three other organisations to boost support for melanoma patients and their carers across Australia.
Melanoma patients and their families across Western Australia will benefit from strengthened and expanded services with the merging of melanomaWA and Melanoma Institute Australia.
Australian researchers have played a critical role in the discovery of a potential new test to predict which early stage melanoma patients are at high risk of their disease recurring and progressing.
We are extremely grateful for our community fundraisers, who, even in this difficult time, have given up their time and effort to fundraise so we can continue to work towards our goal of zero deaths from melanoma.
Melanoma patients are set to benefit from subsidised access to immunotherapy treatment for high risk early-stage and advanced-stage melanoma patients.
An informative article on how immunotherapy is revolutionising cancer treatment, written by Jill Margo and featured in the Australian Financial Review.
Melanoma patients and their families in the Riverina will benefit from strengthened and sustained melanoma services with the merger of the Amie St Clair Melanoma Trust and Melanoma Institute Australia.
Belmont High School at Lake Macquarie has been announced winner of the 2019 SunSafe Student Ambassador Program video competition.
It’s time again to say thank you to our amazing community fundraisers!
Videos of the sessions at the recent Patient Information Evening co-hosted by Melanoma Institute Australia (MIA) and Melanoma Patients Australia (MPA) are now available for viewing.
MIA is well-represented in the poster sessions at the Society for Melanoma Research 2019 Congress in the USA, with four poster presentations being given by members of our translational research lab.